---
title: Skin manifestations after immunisation with an adjuvanted recombinant zoster
  vaccine, Germany, 2020
date: '2023-12-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38099347/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231215170616&v=2.18.0
source: heidelberg[Affiliation]
description: BackgroundShortly after the launch of a novel adjuvanted recombinant
  zoster vaccine (RZV), Shingrix, cases of suspected herpes zoster (HZ) or zoster-like
  skin reactions following immunisation were reported.AimWe aimed to investigate if
  these skin manifestations after administration of RZV could be HZ.MethodsBetween
  April and October 2020, general practitioners (GP) reporting a suspected case of
  HZ or zoster-like skin manifestation after RZV vaccination to the Paul-Ehrlich-Institut,
  the ...
disable_comments: true
---
BackgroundShortly after the launch of a novel adjuvanted recombinant zoster vaccine (RZV), Shingrix, cases of suspected herpes zoster (HZ) or zoster-like skin reactions following immunisation were reported.AimWe aimed to investigate if these skin manifestations after administration of RZV could be HZ.MethodsBetween April and October 2020, general practitioners (GP) reporting a suspected case of HZ or zoster-like skin manifestation after RZV vaccination to the Paul-Ehrlich-Institut, the ...